🚨 New publication! 🚨
We're excited to share our latest paper in Cells:
Stimulus-Based ApoE Alzheimer's Disease Induction Model Using Microglia-Containing Brain Organoids for Drug Discovery.
📄 mdpi.com/2073-4409/15/14/126…
🧵👇
Stem Pharm is heading to Neuroscience 2025 (San Diego, Nov 15–19). We are eager to connect on neuroimmunology across AD, other neurodegenerative disorders, epilepsy, and brain cancers.
▶️ Contact us to schedule a meeting. stempharm.com/contact #SfN25
Big thanks to the Center for Technology Commercialization, Wisconsin Economic Development Corporation, & Wisconsin SBDC for the opportunity to share our work and connect with Wisconsin innovators.
#SBIR #Innovation #Biotech
Great day of neuro-themed talks at the Wisconsin Stem Cell Symposium. Come talk to neural organoid experts at our booth. #neuroscience #organoids
@stempharm wishing you and your loved ones Happy Holidays.
Steve Visuri presenting @stempharm neural in vitro platform for drug discovery at @illumina Accelerator Investor Roundtable meeting. Promising model for targeting neuroinflammation pathways.
@illumina Accelerator CEO dinner featuring start up advice from @TwistBioscience CEO Emily Leproust.
1
Day1 is in the books. Awesome start to @illumina Accelerator.
If you’re at #sfn2019 and want to learn how our synthetic hydrogel substrate can save time and money and yield greater reproducibility in neural cell differentiation and maturation, see @stempharm at poster DD61 today.
1













